» Articles » PMID: 21538235

Candida Albicans, a Major Human Fungal Pathogen

Overview
Journal J Microbiol
Specialty Microbiology
Date 2011 May 4
PMID 21538235
Citations 186
Authors
Affiliations
Soon will be listed here.
Abstract

Candida albicans is the most common human fungal pathogen (Beck-Sague and Jarvis, 1993). It is normally a harmless commensal organism. However, it is a opportunistic pathogen for some immunologically weak and immunocompromised people. It is responsible for painful mucosal infections such as the vaginitis in women and oral-pharangeal thrush in AIDS patients. In certain groups of vulnerable patients it causes severe, life-threatening bloodstream infections and it causes severe, life-threatening bloodstream infections and subsequent infections in the internal organs. There are various fascinating features of the C. albicans life cycle and biology that have made the pathogen the subject of extensive research, including its ability to grow in unicellular yeast, pseudohyphal, and hyphal forms (Fig. 1A); its ability to switch between different but stable phenotypic states, and the way that it retains the ability to mate but apparently loses the ability to go through meiosis to complete the sexual cycle. This research has been greatly facilitated by the derivation of the complete C. albicans genome sequence (Braun et al., 2005), the development of a variety of molecular tools for gene manipulation, and a store of underpinning knowledge of cell biology borrowed from the distantly related model yeast Saccharomyces cerevisiae (Berman and Sudbery, 2002; Noble and Johnson, 2007). This review will provide a brief overview of the importance of C. albicans as a public health issue, the experimental tools developed to study its fascinating biology, and some examples of how these have been applied.

Citing Articles

Improves Survival of and Mice During Lethal Infection with .

Costa A, Motta E, Oliveira A, Santos P, Farias J, Franco D Antibiotics (Basel). 2025; 14(1).

PMID: 39858358 PMC: 11762393. DOI: 10.3390/antibiotics14010072.


Candida albicans cells exhibit media specific proteomic profiles during induction of filamentation.

Veronique L, Veronique A, Guillaume C, Jean-Michel C, Francoise A BMC Microbiol. 2024; 24(1):500.

PMID: 39592958 PMC: 11600622. DOI: 10.1186/s12866-024-03627-4.


Candida albicans pathways that protect against organic peroxides and lipid peroxidation.

Swenson K, Min K, Konopka J PLoS Genet. 2024; 20(10):e1011455.

PMID: 39432552 PMC: 11527291. DOI: 10.1371/journal.pgen.1011455.


Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?.

Prandovszky E, Severance E, Splan V, Liu H, Xiao J, Yolken R Front Cell Infect Microbiol. 2024; 14:1415079.

PMID: 39403206 PMC: 11471644. DOI: 10.3389/fcimb.2024.1415079.


Effect of the gene on the pathogenicity of and immune function .

Li M, Wang H, Zhao H, Jiang M, Cui M, Jia K Heliyon. 2024; 10(19):e38219.

PMID: 39397919 PMC: 11467569. DOI: 10.1016/j.heliyon.2024.e38219.


References
1.
Santos M, Tuite M . The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids Res. 1995; 23(9):1481-6. PMC: 306886. DOI: 10.1093/nar/23.9.1481. View

2.
Biswas S, Van Dijck P, Datta A . Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev. 2007; 71(2):348-76. PMC: 1899878. DOI: 10.1128/MMBR.00009-06. View

3.
Staab J, Sundstrom P . URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol. 2003; 11(2):69-73. DOI: 10.1016/s0966-842x(02)00029-x. View

4.
Daniels K, Srikantha T, Lockhart S, Pujol C, Soll D . Opaque cells signal white cells to form biofilms in Candida albicans. EMBO J. 2006; 25(10):2240-52. PMC: 1462973. DOI: 10.1038/sj.emboj.7601099. View

5.
Braun B, van het Hoog M, dEnfert C, Martchenko M, Dungan J, Kuo A . A human-curated annotation of the Candida albicans genome. PLoS Genet. 2005; 1(1):36-57. PMC: 1183520. DOI: 10.1371/journal.pgen.0010001. View